Odisha News, Odisha Latest news, Odisha Daily - OrissaPOST
  • Home
  • Trending
  • State
  • Metro
  • National
  • International
  • Business
  • Feature
  • Entertainment
  • Sports
  • More..
    • Odisha Special
    • Editorial
    • Opinion
    • Careers
    • Sci-Tech
    • Timeout
    • Horoscope
    • Today’s Pic
  • Video
  • Epaper
  • News in Odia
  • Home
  • Trending
  • State
  • Metro
  • National
  • International
  • Business
  • Feature
  • Entertainment
  • Sports
  • More..
    • Odisha Special
    • Editorial
    • Opinion
    • Careers
    • Sci-Tech
    • Timeout
    • Horoscope
    • Today’s Pic
  • Video
  • Epaper
  • News in Odia
No Result
View All Result
OrissaPOST - Odisha Latest news, English Daily -
No Result
View All Result
EVOS

Facts you need to know about COVID-19 vaccines: Read on for details

Agencies
Updated: December 29th, 2020, 17:25 IST
in Coronavirus, Feature, Sci-Tech
0
Pfizer vaccine

Photo courtesy: ft.com

Share on FacebookShare on TwitterShare on WhatsAppShare on Linkedin

New York: Pharmaceutical giants Pfizer and Moderna have published data showing their COVID-19 vaccines to be more than 90% effective. The results of the two companies have been lauded the world over as a major achievement in the field of science. Above all the vaccines have been given a new ray of hope to the entire world. The Pfizer-BioNTech COVID-19 vaccine has already received emergency use authorisation in countries like the UK, the USA and Bahrain. Vaccination have already started in these countries.

But amid the excitement, misinformation about these vaccines is still spreading online. Questions like so ‘how do these vaccines work? Are they safe? How long will their effect last?’ are doing the rounds.

Also Read

Viral video

Viral video: A bull charges, and this man does the unthinkable!

5 hours ago
Viral video

Viral video: A normal day turns terrifying for this traffic cop!

7 hours ago

Here are some important points that one needs to know to clear doubts.

The COVID-19 vaccines developed by Pfizer and Moderna work by delivering some of the virus’s genetic material into the body without administering any actual viral components. This approach, using a type of molecule called messenger RNA, has never before been approved. But according to experts, using a naturally occurring molecule is a source of reassurance.

“It is a new type of vaccine, but remember, we all have messenger RNA in our body,” Dr Paul Offit, a vaccine expert at the Children’s Hospital of Philadelphia and a member of the FDA’s advisory panel has been quoted as saying by ‘Reuters’. “It’s not like it’s a novel molecule – it’s a molecule that we all see,” he added.

Both the Pfizer and Moderna products were tested using essentially the same criteria as other vaccines

The speed at which these vaccine trials were conducted has raised concerns about the quality and design of their supporting research. However, while the trials were conducted in a relatively short amount of time, they still mirrored traditional vaccine trials.

Vaccination
Vaccination is currently on in the UK PTI photo

For these trials ‘the construct is the same,” Offit explained. “Roughly half get placebo and half get the vaccine, and then they’re followed for a certain period of time.”

We don’t know how long we’re protected

Although many expect the vaccines will be granted emergency authorisation, regulators are waiting on more data before granting a full approval. That’s because one major difference between the ongoing COVID-19 vaccine trials and similar previous trials is the length of follow-up time.

Also read: Pfizer and BioNTech to supply additional 100 million doses of COVID-19 vaccine to US

“In terms of efficacy, you’re only going to know that the vaccine is effective for a couple months, maybe three months. You don’t know if it’s effective for six months or a year, and that’s the critical difference,” Offit explained. “That’s why the FDA is not licensing this product – because it wouldn’t be licensed within such a short period of time,” he added.

Vaccines are generally safe in the long-term. And these are likely no different.

For some, the speed of a likely FDA authorisation raises a concern about whether long-term side effects may be missed. Experts largely aren’t overly concerned, based on what they’ve seen with earlier vaccines. Long-term side effects from vaccines are extremely rare. Bad reactions typically happen within a few weeks of receiving a shot.

A second reason experts are less worried is because there will be regular monitoring of all vaccine recipients, meaning if complications arise they can quickly be addressed.

Vaccines are our best chance of returning to normal

Vaccine specialists interviewed by ‘ABC News’ said that authorising a COVID-19 vaccine includes a careful weighing of risks and rewards, and that the data collected so far show that they’re safe. Normally, vaccine studies take two or three years, but that’s not really an option during the COVID-19 pandemic.

Do you want to wait to do a two- or three-year trial when 260,000 people died this year?” Offit said. “And so far, the clinical trials have mitigated a critical amount of risk,” he added.

 

Tags: COVID-19ModernapandemicPfizerside effectsTrialsvaccines
ShareTweetSendShare
Suggest A Correction

Enter your email to get our daily news in your inbox.

 

OrissaPOST epaper Sunday POST OrissaPOST epaper

Click Here: Plastic Free Odisha

#MyPaperBagChallenge

Adrita Bhattacharya

December 12, 2019
#MyPaperBagChallenge

Nishikant Rout

December 12, 2019
#MyPaperBagChallenge

Diptiranjan Biswal

December 12, 2019
#MyPaperBagChallenge

Subhajyoti Mohanty

December 12, 2019
#MyPaperBagChallenge

Tabish Maaz

December 12, 2019
#MyPaperBagChallenge

Manas Samanta

December 12, 2019
#MyPaperBagChallenge

Geetanjali Patro

December 12, 2019
?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
#MyPaperBagChallenge

Dibya Ranjan Das

December 12, 2019
#MyPaperBagChallenge

Aman Kumar Barisal

December 12, 2019
#MyPaperBagChallenge

Keshab Chandra Rout

December 12, 2019
#MyPaperBagChallenge

Adweeti Bhattacharya

December 12, 2019
#MyPaperBagChallenge

Ankita Balabantray

December 12, 2019
#MyPaperBagChallenge

Subhajyoti Mohanty

December 12, 2019
#MyPaperBagChallenge

Sisirkumar Maharana

December 12, 2019
#MyPaperBagChallenge

Akriti Negi

December 12, 2019
#MyPaperBagChallenge

Ramakanta Sahoo

December 12, 2019
#MyPaperBagChallenge

D Rama Rao

December 12, 2019
#MyPaperBagChallenge

Pragyan Priyambada

December 12, 2019
#MyPaperBagChallenge

Debasis Mohanty

December 12, 2019
#MyPaperBagChallenge

Parbati Mohanty

December 12, 2019
#MyPaperBagChallenge

Saishree Satyarupa

December 12, 2019
#MyPaperBagChallenge

Ipsita

December 12, 2019
#MyPaperBagChallenge

Aishwarya Ranjan Mohanty

December 12, 2019
#MyPaperBagChallenge

Archana Parida

December 12, 2019
#MyPaperBagChallenge

Praptimayee Biswal

December 12, 2019
#MyPaperBagChallenge

Kamana Singh

December 12, 2019
#MyPaperBagChallenge

Anshuman Sahoo

December 12, 2019
#MyPaperBagChallenge

Amritansh Mishra

December 12, 2019
#MyPaperBagChallenge

Rajashree Manasa Mohanty

December 12, 2019
#MyPaperBagChallenge

Tapaswini Mallick

December 12, 2019

Archives

Editorial

‘Smooth Transition’

Silent Shift
December 6, 2025

Andhra Pradesh seems to have decided that the safest way to navigate the future is to stop time itself, at...

Read moreDetails

Trump-Maduro Tensions

December 3, 2025

Tensions between the US and Venezuela have reached a seemingly critical level over what the US administration ostensibly calls its...

Read moreDetails

Indo-China Hiccups

India, China
December 2, 2025

Despite the newfound bonhomie between China and India in the wake of US President Donald Trump’s tariff war, China is...

Read moreDetails

Credibility Loss

Sri Lanka's IMF bailout to wait until the New Year: FM Semasinghe
December 1, 2025

In its latest annual review, the International Monetary Fund (IMF) has assigned a ‘C’ grade to India’s national accounts statistics...

Read moreDetails
  • Home
  • State
  • Metro
  • National
  • International
  • Business
  • Editorial
  • Opinion
  • Sports
  • About Us
  • Advertise
  • Contact Us
  • Jobs
Developed By Ratna Technology

© 2025 All rights Reserved by OrissaPOST

  • News in Odia
  • Orissa POST Epaper
  • Video
  • Home
  • Trending
  • Metro
  • State
  • Odisha Special
  • National
  • International
  • Sports
  • Business
  • Editorial
  • Entertainment
  • Horoscope
  • Careers
  • Feature
  • Today’s Pic
  • Opinion
  • Sci-Tech
  • About Us
  • Contact Us
  • Jobs

© 2025 All rights Reserved by OrissaPOST

    • News in Odia
    • Orissa POST Epaper
    • Video
    • Home
    • Trending
    • Metro
    • State
    • Odisha Special
    • National
    • International
    • Sports
    • Business
    • Editorial
    • Entertainment
    • Horoscope
    • Careers
    • Feature
    • Today’s Pic
    • Opinion
    • Sci-Tech
    • About Us
    • Contact Us
    • Jobs

    © 2025 All rights Reserved by OrissaPOST